Remove 2028 Remove Healthcare Remove Leads
article thumbnail

Medicare savings won’t make a dent in healthcare costs

World of DTC Marketing

SUMMARY: Allowing Medicare to negotiate drug prices is popular with voters because the media has been focused on the high price of some drugs, but this measure won’t lead to lower healthcare costs. The drug industry is trying to convince voters that government negotiations with drug companies will lead to less innovation.

article thumbnail

Your Guide to Virtual Reality Reimbursement in the U.S. Healthcare Market

Nixon Gwilt Law

As a law firm focused specifically on healthcare innovation, we get really excited about developing areas of the healthcare industry. Digital health companies building VR solutions often ask us this question, and if you are a founder or executive looking for ways to commercialize your VR platform for healthcare providers in the U.S.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The EU AI Act: will regulation drive life science innovation away from Europe?

European Pharmaceutical Review

The absence of adequate infrastructure mirrors the issues encountered by MDR and IVDR, leading to delays because notified bodies were not adequately prepared and did not have adequate capacity. Michael has nearly 20 years of knowledge and experience leading localised and global teams in regulatory affairs and quality assurance.

Medical 105
article thumbnail

Pharma’s reputational high will be short-lived

World of DTC Marketing

A great example of pharma’s profiteering is biosimilar drugs which cost a lot and add billions of dollars to healthcare costs. Fierce Pharma just reported, “a big question hanging over AbbVie CEO Richard Gonzalez is whether he can lead the Illinois pharma safely through the patent cliff of its revenue cornerstone Humira.

Pharma 186
article thumbnail

Emerging Trends in Orthopedic Medical Device Industry

Medico Reach

What really matters are the orthopedic medical device trends that are already shaping the healthcare industry. Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. million by 2028. Healthcare executives are also looking into AR spinal surgical systems.

Medical 98
article thumbnail

H2 2022 to see the decline of Covid-19 vaccines as forecasts decrease

Pharmaceutical Technology

These are forecast to generate $264 billion in sales between 2021 and 2028. Comirnaty, which was first approved in the UK by an Emergency Use Approval (EUA) from the Medicines and Healthcare products Regulatory Agency (MHRA) on December 2, 2020, is currently the leading prophylactic vaccine with 2021 sales of $41.5

Sales 52
article thumbnail

Viatris to acquire Oyster Point and Famy Life Sciences

Pharmaceutical Technology

These acquisitions could possibly add a minimum of $1bn in sales of Viatris by 2028. This will form the foundation to establish a leading international ophthalmology franchise, expediting work for addressing the unmet needs in the area of ophthalmic diseases. Famy Life Sciences has an ophthalmology portfolio that complements Viatris.